PROCTER & GAMBLE Co — Annual Report 2013

Sep 20, 2013

11-K 1 uk141.htm 2013 PROCTER & GAMBLE 1-4-1 PLAN uk141.htm Licensed to: Procter & Gamble Document Created using EDGARizer 2020 5.4.3.1 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 11-K

[ X ] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] FOR THE FISCAL YEAR ENDED JUNE 30, 2013, OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED] for the transition period from ___ to____.

Commission file number 001-00434

A. Full title of the plan and the address of the plan, if different from that of the issuer named below: Procter & Gamble 1-4-1 Plan, Procter & Gamble Technical Centres Limited, Cobalt 12, Silver Fox Way, Cobalt Business Park, Newcastle upon Tyne NE27 0QW.

B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: The Procter & Gamble Company, One Procter & Gamble Plaza, Cincinnati, Ohio 45202

REQUIRED INFORMATION

ITEM 1. Audited statements of financial condition as of the end of the latest two fiscal years of the plan (or such lesser period as the plan has been in existence). (See Page 2)

ITEM 2. Audited statements of income and changes in plan equity for each of the latest three fiscal years of the plan (or such lesser period as the plan has been in existence). (See Page 3)

PROCTER & GAMBLE 1-4-1 PLAN Statements of Net Assets Available for Plan Benefits as of June 30, 2013 and 2012, Statements of Changes in Net Assets Available for Plan Benefits for the Years Ended June 30, 2013, 2012 and 2011, and Report of Independent Registered Public Accounting Firm

TABLE OF CONTENTS
	Page
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	1
FINANCIAL STATEMENTS:
Statements of Net Assets Available for Plan Benefits as of June 30, 2013 and 2012	2
Statements of Changes in Net Assets Available for Plan Benefits for the Years Ended June 30, 2013, 2012 and 2011	3
Notes to Financial Statements for the Years Ended June 30, 2013, 2012 and 2011	4

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Trustees of the Procter & Gamble 1-4-1 Plan:

We have audited the accompanying statements of net assets available for plan benefits of the Procter & Gamble 1-4-1 Plan (“Plan”) as of June 30, 2013 and 2012, and the related statements of changes in net assets available for plan benefits for each of the three years ended June 30, 2013, 2012 and 2011. These financial statements are the responsibility of the plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such financial statements present fairly, in all material respects, the net assets available for plan benefits of the Plan as of June 30, 2013 and 2012 and the changes in net assets available for plan benefits for the years ended June 30, 2013, 2012 and 2011, in conformity with accounting principles generally accepted in the United States of America.

/s/ Deloitte LLP

Deloitte LLP

Newcastle upon Tyne, United Kingdom

September 20, 2013

1

PROCTER & GAMBLE

1-4-1 PLAN

STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS
JUNE 30, 2013 AND 2012
	2013	2012
	£	£
ASSETS:
Investment in The Procter & Gamble Company common stock, at fair value	59,209,588	48,722,283
(1,169,349 shares at 30 June 2013, 1,241,404 shares at 30 June 2012)
Cash at bank and in hand	515,838	991,036
Total assets	59,725,426	49,713,319
LIABILITIES:
Contributions received in advance	(77,998)	(602,295)
Total liabilities	(77,998)	(602,295)
NET ASSETS AVAILABLE FOR PLAN BENEFITS	59,647,428	49,111,024

2

PROCTER & GAMBLE

1-4-1 PLAN

STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS
FOR THE YEARS ENDED JUNE 30, 2013, 2012 AND 2011
ADDITIONS/ (LOSSES):	2013	2012	2011
	£	£	£
Contributions:
Employee contributions	3,380,272	3,653,523	3,546,451
Employer contributions (Note 7)	3,380,272	3,653,523	3,546,451
Total contributions	6,760,544	7,307,046	7,092,902
Investment income:
Net appreciation / (depreciation) in fair value of The Procter &
Gamble Company common stock (Note 4)	13,634,703	(325,287)	(300,649)
Dividends from The Procter & Gamble Company common stock (Note 7)	1,455,037	1,304,242	1,165,988
Total investment income	15,089,740	978,955	865,339
Income from participating Procter & Gamble companies (Note 7)	45,683	16,375	39,338
Total additions	21,895,967	8,302,376	7,997,579
DEDUCTIONS:
Distributions and withdrawals to participants	(11,313,880)	(6,705,240)	(5,552,173)
Administrative expenses	(45,683)	(16,375)	(39,338)
Total deductions	(11,359,563)	(6,721,615)	(5,591,511)
INCREASE IN NET ASSETS	10,536,404	1,580,761	2,406,068
NET ASSETS AVAILABLE FOR PLAN BENEFITS:
Beginning of year	49,111,024	47,530,263	45,124,195
End of year	59,647,428	49,111,024	47,530,263

3

PROCTER & GAMBLE

1-4-1 PLAN

NOTES TO FINANCIAL STATEMENTS AS OF

JUNE 30, 2013 AND 2012 AND FOR THE YEARS ENDED JUNE 30, 2013, 2012 AND 2011.

1. DESCRIPTION OF THE PLAN

The Procter & Gamble 1-4-1 Plan (the “Plan”) is a stock ownership plan sponsored by The Procter & Gamble Company (“Company”). The following brief description of the Procter & Gamble 1-4-1 Plan (“Plan”) is provided for general information purposes only. Participants should refer to the Plan agreement for more complete information.

General - The Plan is a share purchase plan established by Procter & Gamble to provide a means for eligible United Kingdom (“UK”) employees to tax efficiently purchase shares of the Company. The Plan is administered by Capita IRG Trustees Limited who were appointed by the Trustees of the Plan and hold the Plan assets on behalf of the Trustees of the Plan.

Eligibility — Employees eligible to participate in the Plan included all regular employees of participating subsidiaries of the Company (Note 6) with the exception of employees considered to be an executive, officer, director, or a 10 percent stockholder of the Company and employees eligible for another savings plan sponsored by the Company and maintained in the United States, Canada, or Puerto Rico. Eligible employees could have enrolled in the Plan on the first day of each month and on the initial participation date for each participating Procter & Gamble Company.

Distributions and Withdrawals – Participants may withdraw contributory shares from the Plan at any time; however, participants who withdraw contributory shares from the Plan within five years of acquisition will become liable for UK income tax and national insurance. Participants cannot withdraw matching shares from the Plan within five years of purchase, unless the participant ceases to be an employee of one of the participating companies. Participants who withdraw shares from the Plan after five years can do so without attracting any income tax.

Contributions - Contributions represent cash amounts received from members, matched by the participating Procter & Gamble companies (Note 6), that have been invested in stock of the Company. Employees can contribute up to 2.5% of their base salary. Where cash amounts are received from members and matched by the sponsoring companies, but have not yet been invested in stock of the Company, they are deferred on the statement of net assets available for plan benefits.

Participant Accounts – Individual accounts are maintained for each Plan participant. Each participant’s account is credited with the participant’s contribution, the participating companies’ matching contribution, and allocations of Plan earnings, and charged with withdrawals and an allocation of Plan losses. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is limited to the shares that can be provided from the participant’s vested account.

Participant accounts remaining in the Plan continue to have individual accounts maintained with Plan earnings or losses allocated based on earnings and account balances as defined.

Vesting – Participants are vested immediately in all shares and contributions allocated to their respective Plan accounts. The participating Procter and Gamble companies match contributions.

Investments - All employee and employer contributions were invested in shares of the Company’s common stock generally on the 5th working day of each month. Sales of the Company’s common stock for distributions generally also occur on the 5th working day of each month. Any dividends on shares of the Company’s common stock are invested in additional shares of the Company’s common stock.

Participant Loans – Under the terms of the Plan agreement, participants are not permitted to borrow funds from their account balance.

4

PROCTER & GAMBLE

1-4-1 PLAN

1. SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting - The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and changes therein and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Risks and Uncertainties - The Plan invests in Company common stock which represents a concentration in investments. Investment securities, in general, are exposed to various risks, such as interest rate, credit and overall market volatility. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and such change could materially affect the value of the participants' account balances and the amounts reported in the financial statements.

Investment Valuation and Income Recognition – The Plan’s investment in Company common stock is stated at fair value, which is based on quoted market prices and is translated into sterling at the rate of exchange at the balance sheet date. Purchases and sales of securities are recorded on a trade date basis. Dividends are recorded on the ex-dividend date, net of any U.S. withholding taxes. Realized gains and losses are based upon the identified cost method.

Net Appreciation / (Depreciation) in Fair Value of Investments - Realised and unrealised appreciation / (depreciation) in fair value of investments is based on the difference between the fair value of the assets at the beginning of the year, or at the time of purchase for assets purchased during the year, and the related fair value on the day investments are sold with respect to realised appreciation / (depreciation), or on the last day of the year for unrealised appreciation / (depreciation).

Cash at Bank and In Hand – Amounts shown as cash at bank and in hand are uninvested funds held that are to be invested in Company common stock in the following month.

Expenses of the Plan - Investment management expenses and all other fees and expenses are reimbursed by the participating Procter & Gamble companies (Note 6).

Fair Value Measurements and Disclosures — In May 2011, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) no. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs , which amends Accounting Standards Codification (“ASC”) 820. ASU 2011-04 also required the categorization by level for items that are only required to be disclosed at fair value and information about transfers between Level 1 and Level 2. In addition, the ASU provides guidance on measuring the fair value of financial instruments managed within a portfolio and the application of premiums and discounts on fair value measurements. The Plan adopted this guidance on July 1, 2012. The effect of the adoption of ASU 2011-04 had no impact on the Plan’s statement of net assets available for plan benefits and the statement of changes in net assets available for plan benefits.

5

PROCTER & GAMBLE

1-4-1 PLAN

1. FAIR VALUE MEASUREMENTS

ASC Topic 820, establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described as follows:

Level 1	Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the plan has the ability to access.
Level 2	Inputs to the valuation methodology include • quoted prices for similar assets or liabilities in active markets; • quoted prices for identical or similar assets or liabilities in inactive markets; • inputs other than quoted prices that are observable for the asset or liability; • inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.
Level 3	Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

All investments are measured following a Level 1 valuation technique.

1. INVESTMENTS

The Plan’s investment in Company common stock experienced net appreciation/ (depreciation) in value as follows for the years ended June 30, 2013, 2012, and 2011:

	2013	2012	2011
	£	£	£
The Procter & Gamble Company common stock:
Net apppreciation/ (depreciation)	13,634,703	(325,287)	(300,649)

6

PROCTER & GAMBLE

1-4-1 PLAN

1. TAX STATUS

HM Revenue & Customs (HMRC) has determined and informed the Company that it is an approved Employee Share Scheme under UK tax legislation. Therefore, the Plan Administrator believes that the Plan was qualified and tax-exempt as of June 30, 2013 and no provision for income taxes has been reflected in the accompanying financial statements.

1. PARTICIPATING PROCTER & GAMBLE COMPANIES

The participating Procter & Gamble companies are as follows:

Procter & Gamble Prestige Products Limited

Procter & Gamble Product Supply (UK) Limited

Procter & Gamble Technical Centres Limited

Procter & Gamble (L&CP) Limited

Procter & Gamble (Health & Beauty Care) Limited

Gillette UK Limited

Gillette Management LLC

Wella (U.K.) Limited

Wella (UK) Holdings Limited

1. RELATED PARTY TRANSACTIONS

At June 30, 2013 and 2012, 1,169,349 and 1,241,404 shares of Company common stock were held by the Plan respectively. The cost of this stock at June 30, 2013 and 2012 was £39,524,934 and £39,334,620 respectively. During the years ended June 30, 2013, 2012 and 2011, the Plan recorded dividend income from Company common stock of £1,455,037, £1,304,242 and £1,165,988 respectively. Contributions from participating Procter & Gamble companies of £3,380,272, £3,653,523 and £3,546,451 were recorded for the years ended June 30, 2013, 2012 and 2011, respectively. Also, the Plan received reimbursements for administrative expenses from the participating Procter & Gamble companies for the years ended June 30, 2013, 2012 and 2011 of £45,683, £16,375 and £39,338 respectively.

1. PLAN TERMINATION

Although they have not expressed any intent to do so, the participating Procter & Gamble Companies have the right under the Plan to discontinue their contributions at any time and to terminate the Plan subject to the provisions set forth in the Plan agreement.

7

THE PLAN. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Newcastle upon Tyne United Kingdom, on September 20, 2013.

PROCTER & GAMBLE 1-4-1 PLAN

By: _/s/Susan E. Carver ___

Ms. Susan E. Carver

Trustee,

Procter & Gamble 1-4-1 Plan

EXHIBIT INDEX

Exhibit No.

23 Consent of Deloitte & Touche LLP